Production of pellets from wet masses containing olanzapine by extrusion and spheronization
Production of pellets from wet masses containing olanzapine by extrusion and spheronization
In this study pellets were produced from wet masses containing olanzapine by extrusion and spheronization. This technique is used worldwide to create multiparticulate solid dosage forms. The extrudability of wet masses containing olanzapine into pellets, was tested. First pellets were manufactured containing only microcrystalline cellulose (MCC), tricalcium phosphate (TCP) and water. In the second part of the study, olanzapine was added as active pharmaceutical ingredient. In both parts of the study, pellets were manufactured with different formulations of excipients. Each formulation was extruded 2 times, immediately after mixture, and after 24 hours. The resulting pellets were tested on different properties such as density, porosity, loss on drying, size and crushing force. Finally the release of olanzapine from the pellets was tested, by a dissolution test.
When looking at the results, it can be stated that the fractions of MCC and TCP in the formulation should be balanced in order to obtain pellets with a good size between 1 and 1,4 mm. When water was added to microcrystalline cellulose, the latter tends to swell up and form a matrix structure, which can hold various substances, like olanzapine. Tricalciumphosphate has the property to interconnect the pores inside the pellets, making it more easy for olanzapine to escape from the pellets. The MCC and TCP fractions in formulations was also important for the tensile strenght of the pellets. Conclusions have been made that a formulation should contain more than 20 parts of MCC in order to resist to a crushing force. When less than 20 parts of MCC is used in a formulation, the matrix structure cannot be formed, resulting in pellets which break more easily.
When comparing the different dissolution profiles of pellets with different formulations, pellets with 20 parts MCC and 80 parts TCP have shown the largest olanzapine release. When more MCC is used in the formulation, the matrix structure is formed in that way that the olanzapine cannot be released.
The influences of excipients, such as MCC and TCP, in different fractions on the properties of pellets after extrusion and spheronization were tested in this study. Future work could examine and compare differences in these properties between MCC, TCP, and other excipients.
AGRAWAL, A. M., HOWARD, M. A. & NEAU, S. H. (2004) Extruded and spheronized beads containing no microcrystalline cellulose £%M: Influence of formulation and process variables. Pharmaceutical Development and Technology, 9, 197-217.
AGRAWAL, A. M., MANEK, R. V., KOLLING, W. M. & NEAU, S. H. (2004) Water distribution studies within microcrystalline cellulose and chitosan using differential scanning calorimetry and dynamic vapor sorption analysis. Journal of Pharmaceutical Sciences, 93, 1766-1779.
BAERT, L. & REMON, J. P. (1993) Influence of amount of granulation liquid on the drug-release rate from pellets made by extrusion spheronization. International Journal of Pharmaceutics, 95, 135-141.
BAERT, L., VERMEERSCH, H., REMON, J. P., SMEYERSVERBEKE, J. & MASSART, D. L. (1993) Study of parameters important in the spheronization process. International Journal of Pharmaceutics, 96, 225-229.
BARADARI, H., DAMIA, C., DUTREIH-COLAS, M., CHAMPION, E., CHULIA, D. & VIANA, M. beta-TCP porous pellets as an orthopedic drug delivery system: ibuprofen/carrier physicochemical interactions. Science and Technology of Advanced Materials, 12.
BASHAIWOLDUA, A., PODCZECKB, F., NEWTON, J. M. (2004) A study on the effect of drying techniques on the mechanical properties of pellets and compacted pellets. European Journal of Pharmaceutical Sciences, 21, 119–129.
BATAILLE, B., BARRAU, J. P., RAHMAN, L., LIGARSKI, K., JACOB, M., DURU, C., BAYLAC, G. & PUECH, A. (1990) Optimization of the spheronization step in the manufacture of cellulose-derivative granules using the extrusion-spheronization process. Journal De Pharmacie De Belgique, 45, 125-130.
BATAILLE, B., LIGARSKI, K. & JACOB, M. (1990) Study on wetting parameters and spheronization rate on size and hardness of minigranules prepared by extrusion-spheronization. Pharmaceutica Acta Helvetiae, 65, 334-337.
BATAILLE, B., LIGARSKI, K., JACOB, M., THOMAS, C. & DURU, C. (1993) Study of the influence of spheronization and drying conditions on the physicomechanical properties of neutral spheroids containg avicel PH-101 and lactose. Drug Development and Industrial Pharmacy, 19, 653-671.
BECHARD, S. R. & LEROUX, J. C. (1992) Coated pelletized dosage form – effect of compaction on drug release. Drug Development and Industrial Pharmacy, 18, 1927-1944.
BHANA, N., FOSTER, R. H., OLNEY, R. & PLOSKER, G. L. (2001) Olanzapine - An updated review of its use in the management of schizophrenia. Drugs, 61, 111-161.
CARSTENS.JT, OSADCA, M. & RUBIN, S. H. (1969) Degradation mechanisms for water-soluble drugs in solid dosage forms. Journal of Pharmaceutical Sciences, 58, 549-&.
CHIEN, N., CHRISTENSEN, J. M. & AYRES, J. W. Verapamil sustained release: New formulation and convolution. Pharmaceutical Development and Technology, 17, 148-157.
CONINE, J. W. & HADLEY, H. R. (1970) Preparation of small solid pharmaceutical spheres. Drug & Cosmetic Industry, 106, 38-&.
COSTA, F. O., SOUSA, J. J. S., PAIS, A. & FORMOSINHO, S. J. (2003) Comparison of dissolution profiles of Ibuprofen pellets. Journal of Controlled Release, 89, 199-212.
COSTA, P. (2001) An alternative method to the evaluation of similarity factor in dissolution testing. International Journal of Pharmaceutics, 220, 77-83.
COSTA, P., MANUEL, J. & LOBO, S. (2001) Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences, 13, 123-133.
DIETRICH, R. & BRAUSSE, R. (1988) Validation of the pellets coating process used for a new sustained-release theophylline formulation. Arzneimittel-Forschung/Drug Research, 38-2, 1210-1219.
DUKIC-OTT, A., THOMMES, M., REMON, J. P., KLEINEBUDDE, P. & VERVAET, C. (2009) Production of pellets via extrusion-spheronization without the incorporation of microcrystalline cellulose: A critical review. European Journal of Pharmaceutics and Biopharmaceutics, 71, 38-46.
EERIKAINEN, S. & LINDQVIST, A. S. (1991) The behavior of various fillers in spheronized uncoated and film-coated granules containing slightly water-soluble indomethacin. International Journal of Pharmaceutics, 75, 181-192.
FEKETE, R., ZELKO, R., MARTON, S. & RACZ, I. (1998) Effect of the formulation parameters on the characteristics of pellets. Drug Development and Industrial Pharmacy, 24, 1073-1076.
FIELDEN, K. E., NEWTON, J. M. & ROWE, R. C. (1992) A comparison of the extrusion and spheronization behavior of wet powder masses processed by a ram extruder and a cylindrical extruder. International Journal of Pharmaceutics, 81, 225-233.
FIELDEN, K. E., NEWTON, J. M. & ROWE, R. C. (1993) The influence of moisture-content on spheronization of extrudate processed by a ram extruder. International Journal of Pharmaceutics, 97, 79-92.
FREESE, H. W. & LUKACH, D. Extrusion press die change assembly has one hydraulic cylinder for shearing work piece and second cylinder for transferring die etc. to transfer station. Usm Corp.
FUJITA, R., YOKOYAMA, A., KAWASAKI, T. & KOHGO, T. (2003) Bone augmentation osteogenesis using hydroacyapatite and beta-tricalcium phosphate blocks. Journal of Oral and Maxillofacial Surgery, 61, 1045-1053.
GAMLEN, M. J. (1985) Pellet manufacture for controlled release. Manufacturing Chemist, 56, 55-&.
GHANAM, D. & KLEINEBUDDE, P. Suitability of kappa-carrageenan pellets for the formulation of multiparticulate tablets with modified release. International Journal of Pharmaceutics, 409, 9-18.
HAMEDELNIEL, E. I., BAJDIK, J., KASA, P. & PINTYE-HODI, K. Study of the influence of alkalizing components on matrix pellets prepared by extrusion/spheronization. Pharmaceutical Development and Technology, 17, 204-211.
HARRISON, P. J., NEWTON, J. M. & ROWE, R. C. (1985) The characterization of wet powder masses suitable for extrusion spheronization. Journal of Pharmacy and Pharmacology, 37, 686-691.
HARRISON, P. J., NEWTON, J. M. & ROWE, R. C. (1987) The application of capillary rheometry to the extrusion of wet powder masses. International Journal of Pharmaceutics, 35, 235-242.
HASZNOS, L., LANGER, I. & GYARMATHY, M. (1992) Some factors influencing pellets characteristics made by an extrusion/spheronization process. Effects on size characteristics and moisture-content decrease of pellets. Drug Development and Industrial Pharmacy, 18, 409-437.
HILEMAN, G. A., GOSKONDA, S. R., SPALITTO, A. J. & UPADRASHTA, S. M. (1993) Response-surface optimization of high-dose pellets by extrusion and spheronization. International Journal of Pharmaceutics, 100, 71-79.
HUANG, H. P. & GHEBRESELLASSIE, I. (1989) Preparation of microspheres of water-soluble pharmaceuticals. Journal of Microencapsulation, 6, 219-225.
JACOB, S., NAIR, A., PATIL, P., PANDA, B. (2011) Solid state crystallinity, amorphous state, and its implications in the pharmaceutical process. International journal of pharmaceutical sciences and research, Vol. 2(3): 472-482.
JALAL, I. M., SMITH, W. E. & MALINOWS.HJ (1972) Tablet granulations composed of spherical-shaped particles. Journal of Pharmaceutical Sciences, 61, 1466-&.
KALYUZHNY, G., VASKEVICH, A., ASHKENASY, G., SHANZER, A. & RUBINSTEIN, I. (2000) UV/VIS spectroscopy of metalloporphyrin and metallophthalocyanine monolayers self-assembled on ultrathin gold films. Journal of Physical Chemistry B, 104, 8238-8244.
KAUNISTO, E., MARUCCI, M., BORGQUIST, P. & AXELSSON, A. Mechanistic modelling of drug release from polymer-coated and swelling and dissolving polymer matrix systems. International Journal of Pharmaceutics, 418, 54-77.
KLEINEBUDDE P. (1997) The crystallite-gel-model for microcrystalline cellulose in wet granulation, extrusion and spheronization. Pharm. Res. 14: 804-809
KRUEGER, C., THOMMES, M. & KLEINEBUDDE, P. "MCC SANAQ (R) burst"-A New Type of Cellulose and its Suitability to Prepare Fast Disintegrating Pellets. Journal of Pharmaceutical Innovation, 5, 45-57.
KUNDU, B., LEMOS, A., SOUNDRAPANDIAN, C., SEN, P.S., DATTA, S., FERREIRA J.M.F., BASU, D. (2010) Development of porous HAp and β-TCP scaffolds by starch consolidation with foaming method and drug-chitosan bilayered scaffold based drug delivery system. Journal of Materials Science: Materials in Medicine, Vol. 21, 2955-2969
LAI, B.G., PINTO, J.F., PAISANA, M. (2012) Understanding the kinetics of hydration and dehydration of Olanzapine.
LIANG, JI-ZHAO (2007) Planar entry converging flow during extrusion of polymer melts. Polymer-plastics Technology and engineering, volume 46, issue 5.
LIEW, C. V., LOH, Z. H., HENG, P. W. S. & LEE, C. C. (2008) A study on microwave-induced melt granulation in a single pot high shear processor. Pharmaceutical Development and Technology, 13, 401-411.
MILLILI, G. P. & SCHWARTZ, J. B. (1990) The strength of microcrystalline cellulose pellets – effect of granulating with water ethanol mixtures. Drug Development and Industrial Pharmacy, 16, 1411-1426.
MORRIS, K., GRIESSER, U., ECKHARDT, C., STOWELL, J. (2001) Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Advanced drug delivery reviews, 48, 91-114.
MORTIER, S. T. F. C., DE BEER, T., GERNAEY, K. V., REMON, J. P., VERVAET, C. & NOPENS, I. Mechanistic modelling of fluidized bed drying processes of wet porous granules: A review. European Journal of Pharmaceutics and Biopharmaceutics, 79, 205-225.
MUZIKOVA, J. & NOVAKOVA, P. (2007) A study of the properties of compacts from silicified micro crystalline celluloses. Drug Development and Industrial Pharmacy, 33, 775-781.
NEWTON, J. M., CHAPMAN, S. R. & ROWE, R. C. (1995) The influence of process variables on the preparation and properties of spherical granules by the process of extrusion and spheronization. International Journal of Pharmaceutics, 120, 101-109.
NURNBERG, E. & WUNDERLICH, J. (1996) Simple formulation optimization for extrusion - Influence of particle size, source and preprocessing of microcrystalline celluloses. Pharmazeutische Industrie, 58, 653-658.
PINTO, J. F., BUCKTON, G. & NEWTON, J. M. (1992) The influence of 4 selected processing and formulation factors on the production of spheres by extrusion and spheronization. International Journal of Pharmaceutics, 83, 187-196.
PINTO, J. F., PODCZECK, F. & NEWTON, J. M. (1997) Investigations of tablets prepared from pellets produced by extrusion and spheronisation . Modelling the properties of the tablets produced using regression analysis. International Journal of Pharmaceutics, 152, 7-16.
ROUSSIERE, H., FAYON, F., ALONSO, B., ROUILLON, T., SCHNITZLER, V., VERRON, E., GUICHEUX, J., PETIT, M., MASSIOT, D., JANVIER, P., BOULER, J. M. & BUJOLI, B. (2008) Reaction of zoledronate with beta-tricalcium phosphate for the design of potential drug device combined systems. Chemistry of Materials, 20, 182-191.
ROWE, R. C. (1985) Spheronization – A novel pill-making process. Pharmacy International, 6, 119-123.
SOUSA, J. J., SOUSA, A., PODCZECK, F. & NEWTON, J. M. (2002) Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. International Journal of Pharmaceutics, 232, 91-106.
THOMMES, M. & KLEINEBUDDE, P. (2008) The behavior of different carrageenans in pelletization by extrusion/spheronization. Pharmaceutical Development and Technology, 13, 27-35.
TOBYN, M. J., MCCARTHY, G. P., STANIFORTH, J. N. & EDGE, S. (1998) Physicochemical comparison between microcrystalline cellulose and silicified microcrystalline cellulose. International Journal of Pharmaceutics, 169, 183-194.
TOMER, G., PODCZECK, F. & NEWTON, J. M. (2002) The influence of model drugs on the preparation of pellets by extrusion/spheronization: II spheronization parameters. International Journal of Pharmaceutics, 231, 107-119.
VARUM, F. J. O., MERCHANT, H. A. & BASIT, A. W. Oral modified-release formulations in motion: The relationship between gastrointestinal transit and drug absorption. International Journal of Pharmaceutics, 395, 26-36.
VERSCHUEREN, L. (2010) Evaluatie van extrusie‐sferonisatie voor de productie van sustained release matrix pellets. Katholieke Hogeschool Kempen.
VERVAET, C., BAERT, L. & REMON, J. P. (1995) Extrusion-spheronization – a literature-review. International Journal of Pharmaceutics, 116, 131-146.
VLADYKA, R. S., ERKOBONI, D. F. & SWERIDUK, C. A. Preparation of porous microcrystalline cellulose granules, useful to cushion controlled release particles, comprises granulating microcrystalline cellulose with a granulating fluid, drying at a controlled rate and removing water portions. Scherer Technologies Inc R P.
WOODRUFF, C. W. & NUESSLE, N. O. (1972) Effect of processing variables on particles obtained by extrusion-spheronization processing. Journal of Pharmaceutical Sciences, 61, 787-&.